Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA AL Andreu, MG Hanna, H Reichmann, C Bruno, AS Penn, K Tanji, ... New England Journal of Medicine 341 (14), 1037-1044, 1999 | 496 | 1999 |
Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel A Jouvenceau, LH Eunson, A Spauschus, V Ramesh, SM Zuberi, ... The Lancet 358 (9284), 801-807, 2001 | 477 | 2001 |
Phenotypic spectrum associated with mutations of the mitochondrial polymerase γ gene R Horvath, G Hudson, G Ferrari, N Fütterer, S Ahola, E Lamantea, ... Brain 129 (7), 1674-1684, 2006 | 455 | 2006 |
A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy SM Zuberi, LH Eunson, A Spauschus, R De Silva, J Tolmie, NW Wood, ... Brain 122 (5), 817-825, 1999 | 434 | 1999 |
The primary periodic paralyses: diagnosis, pathogenesis and treatment SL Venance, SC Cannon, D Fialho, B Fontaine, MG Hanna, LJ Ptacek, ... Brain 129 (1), 8-17, 2006 | 400 | 2006 |
Primary episodic ataxias: diagnosis, pathogenesis and treatment JC Jen, TD Graves, EJ Hess, MG Hanna, RC Griggs, RW Baloh, ... Brain 130 (10), 2484-2493, 2007 | 381 | 2007 |
International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in … DA Isenberg, E Allen, V Farewell, MR Ehrenstein, MG Hanna, ... Rheumatology 43 (1), 49-54, 2004 | 368 | 2004 |
MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study JM Morrow, CDJ Sinclair, A Fischmann, PM Machado, MM Reilly, ... The Lancet Neurology 15 (1), 65-77, 2016 | 343 | 2016 |
Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability LH Eunson, R Rea, SM Zuberi, S Youroukos, CP Panayiotopoulos, ... Annals of Neurology: Official Journal of the American Neurological …, 2000 | 321 | 2000 |
Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions HY Lee, Y Huang, N Bruneau, P Roll, EDO Roberson, M Hermann, ... Cell reports 1 (1), 2-12, 2012 | 300 | 2012 |
The UK MRC Mitochondrial Disease Patient Cohort Study: clinical phenotypes associated with the m. 3243A> G mutation—implications for diagnosis and management V Nesbitt, RDS Pitceathly, DM Turnbull, RW Taylor, MG Sweeney, ... Journal of Neurology, Neurosurgery & Psychiatry 84 (8), 936-938, 2013 | 273 | 2013 |
Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia P Imbrici, SL Jaffe, LH Eunson, NP Davies, C Herd, R Robertson, ... Brain 127 (12), 2682-2692, 2004 | 268 | 2004 |
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, ... The Lancet Oncology 22 (11), 1507-1517, 2021 | 254 | 2021 |
The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment E Matthews, D Fialho, SV Tan, SL Venance, SC Cannon, D Sternberg, ... Brain 133 (1), 9-22, 2010 | 253 | 2010 |
Review of the diagnosis and treatment of periodic paralysis JM Statland, B Fontaine, MG Hanna, NE Johnson, JT Kissel, VA Sansone, ... Muscle & nerve 57 (4), 522-530, 2018 | 249 | 2018 |
Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis E Matthews, R Labrum, MG Sweeney, R Sud, A Haworth, PF Chinnery, ... Neurology 72 (18), 1544-1547, 2009 | 236 | 2009 |
Multicentre search for genetic susceptibility loci in sporadic epilepsy syndrome and seizure types: a case-control study GL Cavalleri, ME Weale, KV Shianna, R Singh, JM Lynch, B Grinton, ... The Lancet Neurology 6 (11), 970-980, 2007 | 235 | 2007 |
Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural history RT Murphy, J Mogensen, K McGarry, A Bahl, A Evans, E Osman, P Syrris, ... Journal of the American College of Cardiology 45 (6), 922-930, 2005 | 209 | 2005 |
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders V Salpietro, CL Dixon, H Guo, OD Bello, J Vandrovcova, S Efthymiou, ... Nature communications 10 (1), 3094, 2019 | 201 | 2019 |
Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients I Trender-Gerhard, MG Sweeney, P Schwingenschuh, P Mir, MJ Edwards, ... Journal of Neurology, Neurosurgery & Psychiatry 80 (8), 839-845, 2009 | 199 | 2009 |